title: Case of type 1 diabetes associated with less-dose nivolumab therapy in a melanoma patient.
authors.affiliation: Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Teramoto
authors.affiliation: Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Nakamura
authors.affiliation: Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Yuri
authors.initials: Y
authors.lastname: Asami
authors.affiliation: Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Taichi
authors.initials: T
authors.lastname: Imamura
authors.affiliation: Division of Traumatology and Emergency Acute Medicine, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Shuji
authors.initials: S
authors.lastname: Takahira
authors.affiliation: Division of Traumatology and Emergency Acute Medicine, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Manabu
authors.initials: M
authors.lastname: Nemoto
authors.affiliation: Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
authors.forename: Gota
authors.initials: G
authors.lastname: Sakai
authors.affiliation: Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
authors.forename: Akira
authors.initials: A
authors.lastname: Shimada
authors.affiliation: Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.
authors.forename: Mitsuhiko
authors.initials: M
authors.lastname: Noda
authors.affiliation: Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
authors.forename: Akifumi
authors.initials: A
authors.lastname: Yamamoto
mesh_terms: D000074322:Antineoplastic Agents, Immunological / Q000008:administration & dosage / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced*; D018450:Disease Progression; D005260:Female; D006801:Humans; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D000077594:Nivolumab / Q000008:administration & dosage / Q000009:adverse effects*; D014846:Vulvar Neoplasms / Q000188:drug therapy*
chemical_list: D000074322:Antineoplastic Agents, Immunological; D000077594:Nivolumab